Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

Active, not recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

United States

O'Neal Comprehensive Cancer Center, Birmingham, Alabama

University of California, San Francisco, San Francisco, California

Georgetown University, Washington D.C., District of Columbia

University of Chicago Medicine Comprehensive Cancer Center, Evergreen Park, Illinois

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland